Latest Articles
Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything - The Times of India
Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything The Times of India
Published: Dec. 4, 2025, 3:13 p.m.
Ancient genetics and modern pollutants could provide a clue to endometriosis risk - Bournemouth University
Ancient genetics and modern pollutants could provide a clue to endometriosis risk Bournemouth University
Published: Dec. 4, 2025, 1:48 p.m.
Hematuria Treatment Market Size, Share & Growth Report by 2034 - Straits Research
Hematuria Treatment Market Size, Share & Growth Report by 2034 Straits Research
Published: Dec. 4, 2025, 1:45 p.m.
Absci Announces First Participants Dosed In Phase 1/2A Headline Trial - TradingView
Absci Announces First Participants Dosed In Phase 1/2A Headline Trial TradingView
Published: Dec. 4, 2025, 1:24 p.m.
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia - The Manila Times
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia The Manila Times
Published: Dec. 4, 2025, 1:22 p.m.
Absci Announces First Participants Dosed in Phase 1/2a - GlobeNewswire
Absci Announces First Participants Dosed in Phase 1/2a GlobeNewswire
Published: Dec. 4, 2025, 1 p.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - The Manila Times
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development The Manila Times
Published: Dec. 4, 2025, 12:30 p.m.
Revela Raises £411K Pre-Seed to Develop AI Ultrasound Analysis for Endometriosis Diagnosis - Femtech Insider
Revela Raises £411K Pre-Seed to Develop AI Ultrasound Analysis for Endometriosis Diagnosis Femtech Insider
Published: Dec. 4, 2025, 12:14 p.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - Laotian Times
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development Laotian Times
Published: Dec. 4, 2025, 12:08 p.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - PR Newswire
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development PR Newswire
Published: Dec. 4, 2025, 12:08 p.m.
Link copied to clipboard!